Evaluating The Usage Of Clomipramine in Treating Anorexia Nervosa Among Various Comorbidities

Paper Summary

Anorexia nervosa (AN) is a complex eating disorder often linked to other mental health conditions like OCD and depression, making treatment challenging. This study explores the use of clomipramine (CMI), a medication commonly used for OCD, in treating AN across different patient cases. It reviews three groups: AN patients with OCD, those without any other conditions, and those with additional issues like depression or Tourette’s. Across all groups, clomipramine showed positive effects—patients experienced reduced anorexic behaviors and better nutrition. These improvements were especially notable in cases where AN symptoms resembled OCD patterns, suggesting CMI may help manage obsessive thoughts around food and body image. While the findings are promising, they are based on limited cases. The study recommends future research with larger, more diverse groups to better understand how clomipramine can support recovery in people with anorexia, especially when other mental health conditions are involved.